Interactions between triazoles and amphotericin B against Cryptococcus neoformans (Q33980497)

30 July 2017

title

Interactions between triazoles and amphotericin B against Cryptococcus neoformans (English)

1 reference

30 July 2017

1 reference

Cryptococcus neoformans

1 reference

F Barchiesi

1

1 reference

30 July 2017

A M Schimizzi

2

1 reference

30 July 2017

F Caselli

3

1 reference

30 July 2017

A Novelli

4

1 reference

30 July 2017

S Fallani

5

1 reference

30 July 2017

D Giannini

6

1 reference

30 July 2017

D Arzeni

7

1 reference

30 July 2017

S Di Cesare

8

1 reference

30 July 2017

L F Di Francesco

9

1 reference

30 July 2017

M Fortuna

10

1 reference

30 July 2017

A Giacometti

11

1 reference

30 July 2017

F Carle

12

1 reference

30 July 2017

T Mazzei

13

1 reference

30 July 2017

G Scalise

14

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Antimicrobial Agents and Chemotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

44

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

2435-2441

1 reference

In vitro activities of the new antifungal triazole SCH 56592 against common and emerging yeast pathogens

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

In vitro interaction between amphotericin B and azoles in Candida albicans.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Use of amphotericin B with azole antifungal drugs: what are we doing?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Oral azole drugs as systemic antifungal therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Cross-resistance to polyene and azole drugs in Cryptococcus neoformans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Antagonistic interactions between azoles and amphotericin B with yeasts depend on azole lipophilia for special test conditions in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Treatment of murine cryptococcal meningitis with an SCH 39304-amphotericin B combination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Interactions of amphotericin B and SCH 39304 in the treatment of experimental murine candidiasis: lack of antagonism of a polyene-azole combination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Assay of fluconazole by high-performance liquid chromatography with a mixed-phase column

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

Combination immunotherapy and antifungal chemotherapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90082

In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans

29 October 2018

1 reference

12 December 2020

Treatment of Experimental Cryptococcal Meningitis with Amphotericin B, 5-Fluorocytosine, and Ketoconazole

1 reference

12 December 2020

Combination therapy in experimental invasive aspergillosis

1 reference

12 December 2020

Rapid high performance liquid chromatographic assay for antifungal agents in human sera

1 reference

12 December 2020

Interactions of itraconazole with amphotericin B in the treatment of murine invasive candidiasis

1 reference

12 December 2020

10.1128/AAC.44.9.2435-2441.2000

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference